Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Loss in upcoming 10Q?

IMO, prudence would dictate that they show Q2 as best they can.

I'm in complete agreement.

 

There is a great deal that Turley can do, and have done, with the filing of this 10Q, and time will show if the potential was indeed maximized.

 

 

Be well 

 

Share
New Message
Please login to post a reply